Inventor · disambiguated record
Liliane Goetsch
Also filed as: GOETSCH LILIANE
44 granted patents·25 pending applications·372 citations·filing 2001–2022
98Inventor score
Files withGOETSCH LILIANE31PF MEDICAMENT29MERCK SHARP & DOHME3HAEUW JEAN-FRANCOIS2BEAU-LARVOR CHARLOTTE1
Top patents by PatentIndex Score
69 records- 0195US8545839B2Anti-c-Met antibodyGOETSCH LILIANE·Filed 2010·Granted Oct 1, 2013·20 cites·33 claims
- 0295US8329173B2Antibodies inhibiting c-Met dimerization and uses thereofGOETSCH LILIANE·Filed 2008·Granted Dec 11, 2012·24 cites·27 claims
- 0394US8344112B2IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disordersMERCK SHARP & DOHME·Filed 2008·Granted Jan 1, 2013·41 cites·12 claims
- 0493US9469691B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2014·Granted Oct 18, 2016·8 cites·29 claims
- 0593US7241444B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2003·Granted Jul 10, 2007·95 cites·17 claims
- 0692US8741290B2Anti-cMet antibodyGOETSCH LILIANE·Filed 2009·Granted Jun 3, 2014·15 cites·27 claims
- 0791US9375425B2Combination of a C-Met antagonist and an aminoheteroaryl compound for the treatment of cancerGOETSCH LILIANE·Filed 2015·Granted Jun 28, 2016·4 cites·17 claims
- 0891US9011865B2Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancerPF MEDICAMENT·Filed 2013·Granted Apr 21, 2015·6 cites·17 claims
- 0990US8765128B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2012·Granted Jul 1, 2014·8 cites·14 claims
- 1090US8747850B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2012·Granted Jun 10, 2014·6 cites·56 claims
- 1190US8673302B2Anti-cMet antibody and its use for the detection and the diagnosis of cancerGOETSCH LILIANE·Filed 2010·Granted Mar 18, 2014·9 cites·23 claims
- 1289US7914784B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2007·Granted Mar 29, 2011·10 cites·19 claims
- 1388US10633448B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Apr 28, 2020·4 cites·21 claims
- 1488US8071730B2Anti-JAM-A antibodiesGOETSCH LILIANE·Filed 2008·Granted Dec 6, 2011·7 cites·21 claims
- 1587US10202458B2IGF-1R antibody and its use as addressing vehicle for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Feb 12, 2019·9 cites·24 claims
- 1687US9107907B2Antibodies inhibiting c-Met dimerization, and uses thereofGOETSCH LILIANE·Filed 2012·Granted Aug 18, 2015·6 cites·30 claims
- 1787US8889832B2Antibodies inhibiting c-Met dimerization, and uses thereofGOETSCH LILIANE·Filed 2012·Granted Nov 18, 2014·6 cites·55 claims
- 1887US8871910B2Antibodies inhibiting c-Met dimerization, and uses thereofGOETSCH LILIANE·Filed 2012·Granted Oct 28, 2014·6 cites·55 claims
- 1987US8871909B2Antibodies inhibiting c-Met dimerization and uses thereofGOETSCH LILIANE·Filed 2012·Granted Oct 28, 2014·6 cites·55 claims
- 2087US8361461B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2006·Granted Jan 29, 2013·8 cites·27 claims
- 2187US8124079B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2010·Granted Feb 28, 2012·8 cites·8 claims
- 2286US8729249B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2012·Granted May 20, 2014·4 cites·51 claims
- 2386US7854930B2Anti-igf-ir antibodies and uses thereofPF MEDICAMENT·Filed 2005·Granted Dec 21, 2010·7 cites·8 claims
- 2485US10858423B2Composition for the treatment of IGF-1R expressing cancerPF MEDICAMENT·Filed 2016·Granted Dec 8, 2020·3 cites·14 claims
- 2585US8168410B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2011·Granted May 1, 2012·4 cites·14 claims
- 2685US8101180B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofGOETSCH LILIANE·Filed 2009·Granted Jan 24, 2012·5 cites·12 claims
- 2785US7553485B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofPF MEDICAMENT·Filed 2004·Granted Jun 30, 2009·18 cites·5 claims
- 2884US11219693B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2019·Granted Jan 11, 2022·1 cites·26 claims
- 2984US9173962B2Antigen binding protein and its use as addressing product for the treatment of cancerBEAU-LARVOR CHARLOTTE·Filed 2013·Granted Nov 3, 2015·11 cites·8 claims
- 3084US8623359B2Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancerGOETSCH LILIANE·Filed 2009·Granted Jan 7, 2014·4 cites·17 claims
- 3183US2023406940A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2022·Application pending·0 cites
- 3282US11365259B2IGF-1R antibody and its use as addressing vehicle for the treatment of cancerPF MEDICAMENT·Filed 2018·Granted Jun 21, 2022·2 cites·26 claims
- 3382US10314921B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Jun 11, 2019·3 cites·23 claims
- 3473US2019359717A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2019·Application pending·0 cites
- 3571US10161930B2Antigen binding protein and its use as addressing product for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Dec 25, 2018·1 cites·12 claims
- 3671US9624308B2Antigen binding proteinsPF MEDICAMENT·Filed 2013·Granted Apr 18, 2017·1 cites·14 claims
- 3771US8178096B2Use of an anti-CD151 antibody in the treatment of cancerHAEUW JEAN-FRANCOIS·Filed 2007·Granted May 15, 2012·1 cites·11 claims
- 3870US9689862B2Antigen binding protein and its use as addressing product for the treatment of cancerPF MEDICAMENT·Filed 2012·Granted Jun 27, 2017·1 cites·15 claims
- 3970US2021087278A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2020·Application pending·0 cites
- 4069US2018142024A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2017·Application pending·0 cites
- 4167US9676839B2Process for the modulation of the antagonistic activity of a monoclonal antibodyGOETSCH LILIANE·Filed 2009·Granted Jun 13, 2017·0 cites·7 claims
- 4267US8241646B2Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their usesGOETSCH LILIANE·Filed 2007·Granted Aug 14, 2012·0 cites·23 claims
- 4367US2008193445A1Novel anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2007·Application pending·0 cites
- 4466US2017218071A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2016·Application pending·0 cites
- 4561US2014115727A1NOVEL ANTI-cMET ANTIBODYGOETSCH LILIANE·Filed 2013·Application pending·0 cites
- 4659US11661457B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2020·Granted May 30, 2023·0 cites·23 claims
- 4758US2015078996A1Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disordersMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 4858US2015079080A1Novel anti-igf-ir antibodies and uses thereofMERCK SHARP & DOHME CORP ; INST DE RECH PIERRE FABRE·Filed 2014·Application pending·0 cites
- 4958US2013273031A1Novel anti-igf-ir antibodies and uses thereofINST RECH PIERRE FABRE·Filed 2013·Application pending·0 cites
- 5057US8808667B2Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their usesGOETSCH LILIANE·Filed 2012·Granted Aug 19, 2014·0 cites·22 claims
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →